What did @shans.on.life actually say?
Not much, clinically speaking, and that's worth noting. The creator reported losing two pounds in week five of Mounjaro, described feeling "super super grateful" after a maintenance week, and expressed hope for continued losses. That's the full scope of the claims here.
There's no dosage mentioned, no dietary advice offered, no promises about how fast others will lose weight. This is a personal progress update, not a medical recommendation. The creator isn't telling you what to expect or what to do. They're sharing their own experience, which is a meaningfully different thing. That context matters when we're evaluating what's actually being said versus what viewers might infer from it.
The implied claim, the one most viewers will take away, is that Mounjaro produces steady, consistent weekly weight loss. That's worth examining more carefully.
Does the science back this up?
Broadly, yes. Tirzepatide (the active ingredient in Mounjaro) is one of the most effective weight loss medications ever studied in clinical trials. But the week-to-week pattern the creator describes, with stalls followed by losses, is actually more accurate to real-world experience than the smooth downward curves people expect.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed participants on the highest dose (15mg) lost an average of 20.9% of body weight over 72 weeks. That's substantial. But that average obscures a lot of individual variability. Weight loss on GLP-1 and GIP/GLP-1 receptor agonists like tirzepatide doesn't happen in a straight line. Plateaus, maintenance weeks, and non-linear progress are documented in the literature and are not signs the medication isn't working.
A two-pound loss in a single week sits within a plausible range for an early treatment phase, though individual results vary considerably based on starting weight, dose level, dietary intake, and activity.
What did they get wrong (or right)?
Honestly, they got more right than wrong here, mostly by not saying anything medically questionable at all. The creator didn't overstate their results, didn't claim Mounjaro "fixed" anything, and didn't imply their experience would translate directly to yours. That's actually rarer than it sounds in GLP-1 content on TikTok.
The framing around a maintenance week being followed by a loss is consistent with what researchers call "whoosh" patterns in weight loss, where the body temporarily retains water during fat loss before releasing it. While this concept is somewhat anecdotal in the literature, the underlying physiology of water retention fluctuations during caloric deficit is well-documented.
Where viewers should be cautious is in extrapolating from one person's week-five results. Early weeks on tirzepatide often show more pronounced losses partly due to water weight and reduced food intake, not purely fat loss. Two pounds at week five may look different from two pounds at week twenty-five.
What should you actually know?
If you're watching this video hoping to benchmark your own Mounjaro results against the creator's, that's a reasonable impulse, but the data suggests it's not very useful. The SURMOUNT-1 trial data shows wide variance between participants. Some people lose significantly faster, some slower, and dose escalation schedules heavily influence early results.
Tirzepatide works as a dual GIP and GLP-1 receptor agonist, a mechanism that appears to produce greater weight loss than GLP-1-only drugs like semaglutide, based on head-to-head data from the SURMOUNT-5 trial (Jastreboff et al., 2025, New England Journal of Medicine). But "works better on average" doesn't mean it works the same for everyone.
A maintenance week, like the one the creator references from the previous week, is not a signal that the medication has stopped working. It's a normal part of non-linear weight loss that clinicians routinely see. Stopping or abandoning a medication because of a single stall week would be premature based on the available evidence.
- Weight loss on tirzepatide is non-linear. Stall weeks are expected.
- Two pounds per week is within a plausible but not guaranteed range.
- Individual results depend on dose, diet, starting weight, and adherence.
- This video makes no clinical claims and should not be treated as medical guidance.